BM
Bristol-Myers Squibb
BMY · NYSE
$66.83 -1.85% (-$1.26)
1M +3.24%
Market Cap $139.1B
P/E Ratio 14.98x
Div. Yield 3.69%
ROE 46.75%
Bulios Fair Price
$76.85
15.0% upside
Trenutna cena
$66.83
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BMY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
75 /100
Cheap P/S 2.83x
P/E 14.98x
P/B 6.23x
Growth
31 /100
Declining FCF growth 2.44%
EPS growth 5.36%
Book val. growth 15.90%
Profitability
100 /100
Strong Op. margin 28.27%
Gross margin 70.16%
FCF margin 23.26%
Quality
83 /100
Excellent ROA 10.59%
ROIC 15.47%
Asset turnover 0.56x
Debt
54 /100
Moderate Int. coverage 7.88x
Debt/Equity 1.93x
Net debt/EBITDA 2.06x
Stability
35 /100
Moderate EPS volatility 198.26%
Beta 0.23x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BMY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christopher Boerner
Employees
32,500
Headquarters
Princeton
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report